Physician profile
Brian Smith
NPI 1114938438
$244.87
in general payments reported to CMS, 2019-2025
8 companies · $55.66 in 2025
The $55.66 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.55 · 2020: $22.74 · 2021: $16.73 · 2023: $13.55 · 2024: $118 · 2025: $55.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $100.72 | 2024 | Provenge |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.85 | 2023-2025 | Xifaxan, Plenvu |
| Vanda Pharmaceuticals INC. | $25.10 | 2025 | Fanapt |
| Boston Scientific Corporation | $22.74 | 2020 | |
| Covidien Lp | $18.55 | 2019 | |
| Janssen Biotech, INC. | $16.92 | 2024 | Balversa, Akeega, Erleada |
| Ultragenyx Pharmaceutical INC. | $16.73 | 2021 | |
| Coloplast Corp | $16.26 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.